Developer docs
API playgroundTry for free, no card

Search company profiles

y prime

Full company profile

uuid00037t3

Namestring
y prime
Legal namestring
Y-Prime, LLC
Websiteurl
y-prime.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

YPrime (legally Y-Prime, LLC) is a Malvern, Pennsylvania-based provider of eClinical technology solutions for clinical trials, operating in the space for 16+ years since its founding in 2009. The company offers a unified Clinical Trial Technology Platform comprising four core products: eCOA (electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Patient Engagement, supplemented by Consulting Services. The platform is built on configurable, no-code architecture with pre-validated code and integrated data flows across the three core modules, and is delivered globally across 100+ countries with a 24/7/365 in-house help desk staffed by eClinical experts.

The company serves three primary customer segments: large pharmaceutical sponsors, contract research organizations (CROs), and emerging biotechnology companies, targeting complex global clinical trials across 19+ therapeutic areas including oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology. YPrime has implemented approximately 1,000 clinical studies and its solutions have engaged 125,000+ patients. The firm claims that its enterprise-grade eCOA accelerates study startup timelines by approximately 50% and that its IRT platform supports complex trial designs and rapid protocol amendments without operational bottlenecks. The platform is sold via direct enterprise sales with RFP and Demo CTAs as primary engagement mechanisms, with no evidence of channel or reseller distribution in the available data.

YPrime operates on a subscription-based enterprise SaaS revenue model with quote-based pricing for its technology platform, complemented by professional services revenue from consulting engagements on process optimization, system integration, and inspection readiness. The firm is privately held and PE-backed, having received equity and debt capital from Ballast Point Ventures ($5M, 2013), Square 1 Bank ($5M, 2016), and Flexpoint Ford (2019), and acquired patient engagement specialist Tryl in February 2022 to bolster its participant engagement capabilities. Revenue, valuation, ownership percentages, and the identity of the PE sponsor are not publicly disclosed.

Short descriptiontext

YPrime provides a unified eClinical technology platform—eCOA, IRT, eConsent, and patient engagement—for global clinical trials. It serves pharmaceutical sponsors, CROs, and emerging biotechs across 19+ therapeutic areas and 100+ countries via enterprise SaaS subscriptions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMalvern, United States
HQ citystring
Malvern
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
eCOA solutions, interactive response technology, electronic consent systems, clinical trial software, patient engagement platforms
Industry2 codes
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Other Computer Related Services541519
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Computer Programming Services7371
Product category
Clinical Trial Technology (eClinical)
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1eClinical Technology Platform
TypeSubscription Recurring
Description

Subscription-based access to eCOA, IRT, and eConsent platforms for clinical trials with configurable architecture and global delivery

yprime.com
2Consulting Services
TypeProfessional Services
Description

Expert guidance services extending the clinical trial technology platform including process optimization, regulatory alignment, system integration, and data workflow optimization

yprime.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise platform pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for pharmaceutical sponsors, CROs, and biotech companies; annual or multi-year contract arrangements typical for clinical trial technology

yprime.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

YPrime provides eClinical technology solutions for clinical trials, including electronic Clinical Outcome Assessment (eCOA), Interactive Response Technology (IRT), electronic Consent (eConsent), and patient engagement tools, supporting pharmaceutical sponsors and CROs in accelerating study startup, managing protocol amendments, and ensuring data quality across global clinical trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • ~50% acceleration in clinical trial startup timelines
+2 more records
Product overview1 text field

YPrime offers a unified Clinical Trial Technology Platform comprising four core integrated solutions—eCOA (electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Patient Engagement—supplemented by Consulting Services. The platform is designed for global scale and complex clinical trial protocols across oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology therapeutic areas. Built with configurable architecture and integrated data flows, it enables sponsors and CROs to accelerate study startup, adapt to protocol changes, and maintain data integrity and regulatory oversight throughout trial execution.

Product and service4 records
1eCOA (Electronic Clinical Outcome Assessment)
CategoryClinical Trial Technology
Description

Electronic clinical outcome assessment solution for capturing patient-reported outcomes and clinical endpoint data in regulated clinical trials, intended for pharmaceutical sponsors and CROs.

2IRT (Interactive Response Technology)
CategoryClinical Trial Technology
Description

Interactive response technology system for randomization, patient and drug assignment, and trial supply management in clinical trials, intended for pharmaceutical sponsors and CROs.

3eConsent
CategoryClinical Trial Technology
Description

Electronic informed consent solution for capturing and managing participant consent in clinical trials, intended for pharmaceutical sponsors and CROs.

4Participant Engagement
CategoryClinical Trial Technology
Description

Patient engagement platform for clinical trial participants, supporting participant interaction, reminders, and engagement workflows across global trials, intended for pharmaceutical sponsors and CROs.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Tryl
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-02-09
Description

YPrime acquired Tryl, a company specializing in patient engagement solutions. The acquisition enhances YPrime's patient engagement capabilities within its clinical trial technology platform. PE-backed YPrime completed the acquisition, though specific transaction details were not disclosed.

pehub.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clario (formed from the merger of Bioclinica and ERT) provides eCOA, IRT, cardiac safety, and imaging solutions for clinical trials. Its eCOA franchise competes head-to-head with YPrime's configurable eCOA platform for global, regulated studies.

TypeEmerging player
Description

Castor offers a configurable, cloud-based EDC and eCOA platform aimed at academic and emerging biotech sponsors. It competes with YPrime in the lower-end and mid-market where configurability and speed-to-startup are key buying criteria.

TypeDirect peer
Description

Signant Health (formerly CRF Health and Bracket) specializes in eCOA, eConsent, patient engagement, and clinical rater training. Its focus on patient-centric trial technology directly mirrors YPrime's eCOA + eConsent + patient engagement offering.

TypeBroad incumbent
Description

IQVIA combines CRO services with the Orchestrated Clinical Trials platform (ECT) that includes EDC, RTSM, and eCOA. Its full-service CRO-plus-technology model competes with YPrime for sponsor budgets where services and technology are procured jointly.

TypeDirect peer
Description

Veeva's Vault CDB and Vault EDC extend into eCOA, IRT, and eConsent functionality, sold primarily to large pharma sponsors. Its deep CRM and content-management penetration into the same top-15 pharma accounts makes it a directly comparable competitor in enterprise eClinical RFPs.

TypeEmerging player
Description

ArisGlobal's LifeSphere Clinical platform includes EDC, RTSM, safety, and trial management modules competing for the same mid-tier sponsor RFPs as YPrime. Its broader suite approach mirrors how YPrime competes against larger bundled platforms.

TypeEmerging player
Description

Advarra combines clinical technology (including eRegulatory and eConsent) with IRB and biosafety services for research sites and sponsors. Its eConsent capability partially overlaps with YPrime's offering and is often co-sold with broader technology stacks.

TypeEmerging player
Description

Medrio provides cloud-based EDC, eCOA, and eConsent for clinical trials, with a strong footprint among emerging biotechs and CROs. Its eCOA and eConsent overlap with YPrime's core products for smaller and mid-sized sponsors.

TypeDirect peer
Description

Medidata is the market-leading eClinical platform, offering Rave EDC, eCOA, RTSM/IRT, and eConsent across global clinical trials. It is the most direct large-scale competitor to YPrime's integrated eCOA/IRT/eConsent stack, with substantially greater scale and a broader sponsor footprint.

10Oracle Health Sciences (Clinical One)
TypeBroad incumbent
Description

Oracle's Clinical One platform unifies EDC, RTSM, eCOA, and supply management within Oracle's broader life sciences cloud. As a broad incumbent with deep enterprise IT relationships, Oracle competes in the same eClinical RFPs from a much larger platform footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

y prime

Clinical Trial Technology (eClinical)y-prime.com

YPrime provides a unified eClinical technology platform—eCOA, IRT, eConsent, and patient engagement—for global clinical trials. It serves pharmaceutical sponsors, CROs, and emerging biotechs across 19+ therapeutic areas and 100+ countries via enterprise SaaS subscriptions.

What y prime does

YPrime (legally Y-Prime, LLC) is a Malvern, Pennsylvania-based provider of eClinical technology solutions for clinical trials, operating in the space for 16+ years since its founding in 2009. The company offers a unified Clinical Trial Technology Platform comprising four core products: eCOA (electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Patient Engagement, supplemented by Consulting Services. The platform is built on configurable, no-code architecture with pre-validated code and integrated data flows across the three core modules, and is delivered globally across 100+ countries with a 24/7/365 in-house help desk staffed by eClinical experts.

The company serves three primary customer segments: large pharmaceutical sponsors, contract research organizations (CROs), and emerging biotechnology companies, targeting complex global clinical trials across 19+ therapeutic areas including oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology. YPrime has implemented approximately 1,000 clinical studies and its solutions have engaged 125,000+ patients. The firm claims that its enterprise-grade eCOA accelerates study startup timelines by approximately 50% and that its IRT platform supports complex trial designs and rapid protocol amendments without operational bottlenecks. The platform is sold via direct enterprise sales with RFP and Demo CTAs as primary engagement mechanisms, with no evidence of channel or reseller distribution in the available data.

YPrime operates on a subscription-based enterprise SaaS revenue model with quote-based pricing for its technology platform, complemented by professional services revenue from consulting engagements on process optimization, system integration, and inspection readiness. The firm is privately held and PE-backed, having received equity and debt capital from Ballast Point Ventures ($5M, 2013), Square 1 Bank ($5M, 2016), and Flexpoint Ford (2019), and acquired patient engagement specialist Tryl in February 2022 to bolster its participant engagement capabilities. Revenue, valuation, ownership percentages, and the identity of the PE sponsor are not publicly disclosed.

y prime firmographics

Firmographics
Name
y prime
Legal name
Y-Prime, LLC
Website
https://y-prime.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
251–500 employees
Short description
YPrime provides a unified eClinical technology platform—eCOA, IRT, eConsent, and patient engagement—for global clinical trials. It serves pharmaceutical sponsors, CROs, and emerging biotechs across 19+ therapeutic areas and 100+ countries via enterprise SaaS subscriptions.
Ownership category
akta.pro rank

y prime industry classification

Industry
Product category
Clinical Trial Technology (eClinical)
NAICS
Custom Computer Programming Services (541511), Other Computer Related Services (541519)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • ECOA solutions
  • Interactive response technology
  • Electronic consent systems
  • Clinical trial software
  • Patient engagement platforms

Where y prime is headquartered

Location

Headquarters

HQ city
Malvern
HQ country
United States
HQ region
North America

Markets served

y prime business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. eClinical Technology Platform: Subscription-based access to eCOA, IRT, and eConsent platforms for clinical trials with configurable architecture and global delivery
  2. Consulting Services: Expert guidance services extending the clinical trial technology platform including process optimization, regulatory alignment, system integration, and data workflow optimization

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise platform pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

y prime product offering

Product offering

Core offering

YPrime provides eClinical technology solutions for clinical trials, including electronic Clinical Outcome Assessment (eCOA), Interactive Response Technology (IRT), electronic Consent (eConsent), and patient engagement tools, supporting pharmaceutical sponsors and CROs in accelerating study startup, managing protocol amendments, and ensuring data quality across global clinical trials.

Product overview

YPrime offers a unified Clinical Trial Technology Platform comprising four core integrated solutions—eCOA (electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Patient Engagement—supplemented by Consulting Services. The platform is designed for global scale and complex clinical trial protocols across oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology therapeutic areas. Built with configurable architecture and integrated data flows, it enables sponsors and CROs to accelerate study startup, adapt to protocol changes, and maintain data integrity and regulatory oversight throughout trial execution.

Differentiator

Problem solved

Functional benefit

Products and services

  • eCOA (Electronic Clinical Outcome Assessment) Electronic clinical outcome assessment solution for capturing patient-reported outcomes and clinical endpoint data in regulated clinical trials, intended for pharmaceutical sponsors and CROs.
  • IRT (Interactive Response Technology) Interactive response technology system for randomization, patient and drug assignment, and trial supply management in clinical trials, intended for pharmaceutical sponsors and CROs.
  • eConsent Electronic informed consent solution for capturing and managing participant consent in clinical trials, intended for pharmaceutical sponsors and CROs.
  • Participant Engagement Patient engagement platform for clinical trial participants, supporting participant interaction, reminders, and engagement workflows across global trials, intended for pharmaceutical sponsors and CROs.

Quantifiable outcome

  • ~50% acceleration in clinical trial startup timelines
  • +2 more outcomes

Companies that use y prime

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles1 record

y prime technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

y prime partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TrylminorStrategic or Co-development Partner · 9 February 2022YPrime acquired Tryl, a company specializing in patient engagement solutions. The acquisition enhances YPrime's patient engagement capabilities within its clinical trial technology platform. PE-backed YPrime completed the acquisition, though specific transaction details were not disclosed.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

y prime competitors and assessment

Company assessment

Direct peers

  • Clario: Clario (formed from the merger of Bioclinica and ERT) provides eCOA, IRT, cardiac safety, and imaging solutions for clinical trials. Its eCOA franchise competes head-to-head with YPrime's configurable eCOA platform for global, regulated studies.
  • Signant Health: Signant Health (formerly CRF Health and Bracket) specializes in eCOA, eConsent, patient engagement, and clinical rater training. Its focus on patient-centric trial technology directly mirrors YPrime's eCOA + eConsent + patient engagement offering.
  • Veeva Systems: Veeva's Vault CDB and Vault EDC extend into eCOA, IRT, and eConsent functionality, sold primarily to large pharma sponsors. Its deep CRM and content-management penetration into the same top-15 pharma accounts makes it a directly comparable competitor in enterprise eClinical RFPs.
  • Medidata Solutions (Dassault Systèmes): Medidata is the market-leading eClinical platform, offering Rave EDC, eCOA, RTSM/IRT, and eConsent across global clinical trials. It is the most direct large-scale competitor to YPrime's integrated eCOA/IRT/eConsent stack, with substantially greater scale and a broader sponsor footprint.

Emerging players

  • Castor: Castor offers a configurable, cloud-based EDC and eCOA platform aimed at academic and emerging biotech sponsors. It competes with YPrime in the lower-end and mid-market where configurability and speed-to-startup are key buying criteria.
  • ArisGlobal: ArisGlobal's LifeSphere Clinical platform includes EDC, RTSM, safety, and trial management modules competing for the same mid-tier sponsor RFPs as YPrime. Its broader suite approach mirrors how YPrime competes against larger bundled platforms.
  • Advarra: Advarra combines clinical technology (including eRegulatory and eConsent) with IRB and biosafety services for research sites and sponsors. Its eConsent capability partially overlaps with YPrime's offering and is often co-sold with broader technology stacks.
  • Medrio: Medrio provides cloud-based EDC, eCOA, and eConsent for clinical trials, with a strong footprint among emerging biotechs and CROs. Its eCOA and eConsent overlap with YPrime's core products for smaller and mid-sized sponsors.

Broad incumbents

  • IQVIA: IQVIA combines CRO services with the Orchestrated Clinical Trials platform (ECT) that includes EDC, RTSM, and eCOA. Its full-service CRO-plus-technology model competes with YPrime for sponsor budgets where services and technology are procured jointly.
  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform unifies EDC, RTSM, eCOA, and supply management within Oracle's broader life sciences cloud. As a broad incumbent with deep enterprise IT relationships, Oracle competes in the same eClinical RFPs from a much larger platform footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

y prime social profiles

Digital presence

y prime financial estimates

Financial estimate

Revenue estimate

Valuation estimate

y prime leadership team

Management profile

Number of profiles

y prime subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

y prime funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

y prime M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about y prime

What does y prime do?

YPrime provides eClinical technology solutions for clinical trials, including electronic Clinical Outcome Assessment (eCOA), Interactive Response Technology (IRT), electronic Consent (eConsent), and patient engagement tools, supporting pharmaceutical sponsors and CROs in accelerating study startup, managing protocol amendments, and ensuring data quality across global clinical trials.

Is y prime a public or private company?

y prime is a private company. It is classified as private equity controlled and is currently operating.

When was y prime founded?

y prime was founded in 2009. It employs 251 to 500 people.

Where is y prime based?

y prime is headquartered in Malvern, United States, in the North America region.

How does y prime make money?

Two revenue lines are on record. eClinical Technology Platform is the primary driver. The others are consulting Services.

Who are y prime's main competitors?

Direct peers on record are Clario, Signant Health, Veeva Systems and Medidata Solutions (Dassault Systèmes). Emerging players are Castor, ArisGlobal, Advarra and Medrio. Broad incumbents are IQVIA and Oracle Health Sciences (Clinical One).

Does y prime have an API?

No public API is recorded for y prime.

What industry is y prime in?

y prime's product category is Clinical Trial Technology (eClinical). Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 541511 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales